CMN Weekly (14 April 2023) - Your Weekly CRISPR Medicine News

Some of the best links we picked up around the internet

By: Gorm Palmgren - Apr. 14, 2023
News

#CRISPRMED24

Top picks

Research

Industry

Detection

Reviews

News from CRISPR Medicine News

  • Last Wednesday, just before Easter, we brought the latest CRISPR clinical trial updates from Caribou Biosciences. The company's second gene-edited CAR-T cell therapy candidate, CB-011, has entered the clinic for multiple myeloma. At the same time, dose expansion is set to commence for its frontrunner candidate CB-010, which is being developed to treat non-Hodgkin lymphoma.

To get more of the CRISPR Medicine News delivered to your inbox, sign up to the free weekly CMN Newsletter here.

Tags

HashtagArticleHashtagMissing linksHashtagNewsHashtagCMN Weekly

News: CMN Weekly (14 April 2023) - Your Weekly CRISPR Medicine News
News: CMN Weekly (14 April 2023) - Your Weekly CRISPR Medicine News
CLINICAL TRIALS
Sickle Cell Disease, SCD, (NCT06287099)
Sponsors:
Bioray Laboratories
IND Enabling
Phase I
Phase II
Phase III
IND Enabling
Phase I
Phase II
Phase III
IND Enabling
Phase I
Phase II
Phase III
View all clinical trials
close
Search CRISPR Medicine